LONGIVIYA
CatalogPartnership
Sign in

LONGIVIYA

LONGIVIYA PEPTIDE line products are intended exclusively for scientific research. Products of the other lines are not medicinal products.

Navigation

  • Catalog
  • Partnership
  • Rewards
  • Support

Legal

  • Privacy Policy
  • Public Offer
  • Partnership Agreement
  • Loyalty Program

Contacts

support@longiviya.com

© 2026 KOLLABIUM-FZCO

CatalogRecoveryBlend Premium 80 mg
Blend Premium 80 mgTop
Recovery

Blend Premium 80 mg

4-in-1 recovery, skin, vessels, anti-inflammation

11 500 ₽

Quantity
1

For Research Use Only. Not for human consumption.

11 500 ₽

Blend Premium (BPC-157 + TB-500 + KPV + GHK-Cu) — 80 mg

Purity: ≥98% (HPLC) each component
Form: lyophilized powder, 4 peptides in a single 3 ml vial
Storage: −20 °C (before opening), +2…+8 °C (after reconstitution, no more than 28 days)
Verification: Janoshik Analytical (Czech Republic) — independent blind test of each batch
Composition: BPC-157 + TB-500 + KPV + GHK-Cu


Contents

  1. What is Blend Premium?
  2. Why a combination of four peptides attracts researchers' attention
  3. Component 1 — BPC-157: angiogenesis and tissue repair
  4. Component 2 — TB-500: systemic cell migration
  5. Component 3 — KPV: anti-inflammatory signal
  6. Component 4 — GHK-Cu: matrix remodeling and skin
  7. The logic of the combination — four stages of repair
  8. Sources

1. What is Blend Premium?

Blend Premium is a combination of four research peptides in a single vial. Each of them is studied in the context of tissue repair, but through different mechanisms. The idea behind the composition is to combine peptides that act on different links of a single process — from the suppression of inflammation to the remodeling of the extracellular matrix.

None of the components is approved by regulators as a medicinal product. All data come from preclinical studies (cell cultures and animal models). The BPC-157 + TB-500 combination is known in the research literature as the "Wolverine Stack" — for the accelerated soft-tissue recovery effects described in experiments.

For research use only. Not a medicinal product. Not intended for use in humans or animals.


2. Why the combination attracts researchers' attention

Each peptide individually is well studied. But the interest in their combined use is connected to the fact that they act on different phases of the repair cascade:

  • KPV suppresses the inflammatory signal (NF-κB), reducing the excessive reaction that can slow down recovery [1]
  • TB-500 mobilizes cells and directs them to the site of injury through the regulation of actin [4][5]
  • BPC-157 stimulates angiogenesis — the growth of new blood vessels, ensuring the delivery of nutrients and oxygen to the damaged tissue [2][3]
  • GHK-Cu activates the remodeling of the extracellular matrix — the synthesis of collagen, elastin, and decorin [6][7]

Put simply: one quenches inflammation, the second attracts repair cells, the third builds roads (vessels) to the work site, the fourth restores the tissue scaffold. All four tasks are sequential stages of a single process.

No clinical studies of the combination in humans have been conducted. The data for each component are preclinical.


3. Component 1 — BPC-157: angiogenesis and tissue repair

BPC-157 (Body Protection Compound) is a pentadecapeptide of 15 amino acids, isolated from a protein in human gastric juice. It is one of the most studied repair peptides: more than 100 published studies over the past 30 years.

In experiments on rodents, the following has been described:

  • Accelerated healing of tendons, ligaments, and muscles [2]
  • Stimulation of angiogenesis — the growth of new blood vessels toward the site of injury [3]
  • Dose-dependent recruitment of fibroblasts — the cells responsible for collagen synthesis and the repair of connective tissue
  • Protection of the GI tract mucosa — the original context in which the peptide was discovered

A key feature of BPC-157 is its stability in human gastric juice, which distinguishes it from most peptide growth factors [2].


4. Component 2 — TB-500: systemic cell migration

TB-500 is a fragment of thymosin beta-4 (Thymosin Beta-4, Tβ4), a peptide of 43 amino acids that is present in almost all cells of the body. TB-500 contains the active fragment responsible for a key function: the regulation of actin.

Actin is a cytoskeletal protein without which a cell cannot move. When tissue is damaged, the body needs to "send" stem and progenitor cells to the site of injury. In experiments, TB-500 promotes this process.

In preclinical studies, the following has been described:

  • Enhanced migration of cells to the site of injury [4]
  • Reduction of inflammatory cytokines [5]
  • In cardiac tissue models — a reduction of fibrosis (scarring) and stimulation of repair [5]

If BPC-157 builds the roads (vessels), then TB-500 sends the repair crews (cells) down them.


5. Component 3 — KPV: anti-inflammatory signal

KPV (Lys-Pro-Val) is the C-terminal tripeptide of α-MSH. A detailed description of KPV is available in a separate article in the LONGIVIYA catalog.

Within the context of Blend Premium, KPV plays the role of a "suppressor of excessive inflammation." Inflammation is a necessary stage of repair, but when it drags on it begins to interfere: it destroys tissue, blocks cell migration, and suppresses collagen synthesis.

In experimental models, KPV suppresses the activation of NF-κB — the central regulator of the inflammatory cascade — and reduces the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) [1]. The result: inflammation does not disappear completely (it is needed), but is reduced to a level at which the other components of the blend can work more effectively.


6. Component 4 — GHK-Cu: matrix remodeling and skin

GHK-Cu (glycyl-L-histidyl-L-lysine:copper) is a natural copper-binding tripeptide, first isolated from human blood plasma in 1973 by Loren Pickart.

GHK-Cu is one of the most studied peptides in the field of skin biology. Pickart's review (2015) describes GHK-Cu's ability to modulate the expression of more than 4,000 genes — about a third of the human genome [6]. Among the key effects observed in experiments:

  • Stimulation of the synthesis of type I and III collagen and elastin [7]
  • Stimulation of the synthesis of decorin and glycosaminoglycans — components of the skin's "scaffold"
  • Recruitment of immune cells to the wound and stimulation of angiogenesis
  • Antioxidant activity — the binding of copper ions to superoxide dismutase

Within the context of Blend Premium, GHK-Cu performs the final task: when inflammation is suppressed (KPV), cells are recruited (TB-500), and vessels are built (BPC-157) — GHK-Cu provides the restoration of the structural scaffold of the tissue.


7. The logic of the combination — four stages of repair

Tissue repair is a cascade process consisting of several sequential phases. Each component of Blend Premium is studied in the context of its phase:

PhaseProcessPeptideMechanism
1. InflammationSuppression of the excessive inflammatory responseKPVInhibition of NF-κB and MAPK
2. MigrationRecruitment of cells to the site of injuryTB-500Actin regulation, mobilization of progenitor cells
3. VascularizationGrowth of new vessels to deliver nutritionBPC-157Angiogenesis, stimulation of VEGF
4. RemodelingRestoration of tissue structureGHK-CuSynthesis of collagen, elastin, decorin

This logic is a theoretical model based on the known mechanisms of each component. Studies that would examine the synergy of precisely these four peptides in a single combination have not yet been conducted. Each component has been studied individually within the framework of preclinical models.


Sources

  1. Dalmasso G. et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1): 166–178, 2008. PubMed

  2. Seiwerth S. et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front. Pharmacol., 12: 627533, 2021. PMC

  3. Brcic L. et al. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J. Physiol. Pharmacol., 60(Suppl 7): 191–196, 2009. PubMed

  4. Malinda K.M. et al. Thymosin β4 accelerates wound healing. J. Invest. Dermatol., 113(3): 364–368, 1999. PubMed

  5. Bock-Marquette I. et al. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432: 466–472, 2004. PubMed

  6. Pickart L., Vasquez-Soltero J.M., Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International, 2015: 648108, 2015. PubMed

  7. Pickart L., Margolina A. Skin Regenerative and Anti-Cancer Actions of Copper Peptides. Cosmetics, 5(2): 29, 2018.


This material was prepared by the LONGIVIYA editorial team on the basis of published scientific research. The information is for educational purposes only and does not constitute a medical recommendation.

For research use only. Not a medicinal product. Not intended for use in humans or animals. Independent verification of each batch: Janoshik Analytical (Czech Republic).

For Research Use Only. Not for human consumption.